Title : Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial.

Pub. Date : 2014 Jan

PMID : 24332241






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to assess safety and activity of ibrutinib, an orally administered covalent inhibitor of Bruton tyrosine kinase (BTK), in treatment-naive patients aged 65 years and older with chronic lymphocytic leukaemia. ibrutinib Bruton tyrosine kinase Homo sapiens